Skip to main content
Obsidian Therapeutics, Inc. (OBX)
NASDAQ: OBX · Real-Time Price · USD
12.56
+0.08 (0.64%)
Nov 13, 2026, 4:00 PM EST - Market closed

Obsidian Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024
Period Ending
Nov '26 Dec '25 Dec '24
Last Close Price
12.566.2713.05

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024
Period Ending
Nov '26 Dec '25 Dec '24
Debt / Equity Ratio
0.100.060.04
Net Debt / Equity Ratio
-1.04-1.06-0.99
Net Debt / EBITDA Ratio
0.330.731.80
Net Debt / FCF Ratio
0.340.842.13
Quick Ratio
1.715.2410.46
Current Ratio
2.305.3110.75
Return on Equity (ROE)
--85.41%-
Return on Assets (ROA)
--48.51%-
Return on Capital Employed (ROCE)
-311.20%-144.30%-54.40%

Yields

Fiscal Year
CurrentFY 2025FY 2024
Period Ending
Nov '26 Dec '25 Dec '24
Buyback Yield / Dilution
--8.46%-
SEC Filings: 10-K · 10-Q